Waist circumference reductions were also dose-dependent for Cagrilintide, notably at 1.24.5 mg, exceeding those in the placebo group and approximating the reductions seen with liraglutide 3.0 mg
International scheduling Australia's Therapeutic Goods Administration (interim decision, April 2024) and New Zealand's Medsafe (Medicines Classification Committee, June 2025) have moved to schedule BPC-157 as a prescription-only medicine, despite its unavailability through legitimate prescription
Marine-derived Bacillus species have also shown promise for L-ASNase production
In some cases, regular B12 shots are recommended, especially for those with documented deficiencies, certain health conditions, or specific dietary restrictions that would prevent them from getting B12 from their diet
Kim DH, Lesser TF and Aboseif SR: Subjective patient-reported experiences after surgery for Peyronie's disease: corporeal plication versus plaque incision with vein graft